1. Kjeldsen SE et al. J Hypertens 2008; 26: 2064–70.
2. Simpson et al. BMJ 2006; doi:10.1136/bmj.38875.675486.55.
3. Ho et al. Arch Int Med 2006.
4. Benedict et al. J Hypertens 2006; 24 (Suppl. 4): S140; Cramer et al. Value Health Suppl 2006; 9: A364.
5. World Health Organization 2003; http://www.emro.who.int/ ncd/Publications/adherence_report.pdf.
6. Mourad J, Waeber B, Zinnad F et al. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach. J Hypertens 2004; 22 (12): 2379–86.
7. Gradman AH, Acevedo C. Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep 2002; 4: 343–9.
8. Khan NA, McAlister FA, Lewanczuk RZ et al. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II: therapy. Can J Cardiol 2005; 21: 657–72.
9. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dos combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55 (2): 399–407.
Авторы
И.И.Чукаева
ГБОУ ВПО Российский научно-исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ, Москва